Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 4
1968 3
1969 2
1970 3
1971 5
1972 10
1973 3
1974 6
1975 7
1976 3
1977 7
1978 8
1979 10
1980 7
1981 6
1982 6
1983 12
1984 15
1985 9
1986 9
1987 18
1988 12
1989 11
1990 10
1991 11
1992 12
1993 20
1994 18
1995 17
1996 14
1997 9
1998 17
1999 15
2000 7
2001 17
2002 11
2003 17
2004 17
2005 22
2006 26
2007 16
2008 16
2009 18
2010 15
2011 14
2012 20
2013 24
2014 32
2015 27
2016 20
2017 21
2018 18
2019 27
2020 32
2021 48
2022 39
2023 32
2024 33
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

825 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial.
Lafayette R, Kristensen J, Stone A, Floege J, Tesař V, Trimarchi H, Zhang H, Eren N, Paliege A, Reich HN, Rovin BH, Barratt J; NefIgArd trial investigators. Lafayette R, et al. Among authors: kristensen j. Lancet. 2023 Sep 9;402(10405):859-870. doi: 10.1016/S0140-6736(23)01554-4. Epub 2023 Aug 14. Lancet. 2023. PMID: 37591292 Clinical Trial.
Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy.
Barratt J, Lafayette R, Kristensen J, Stone A, Cattran D, Floege J, Tesar V, Trimarchi H, Zhang H, Eren N, Paliege A, Rovin BH; NefIgArd Trial Investigators. Barratt J, et al. Among authors: kristensen j. Kidney Int. 2023 Feb;103(2):391-402. doi: 10.1016/j.kint.2022.09.017. Epub 2022 Oct 19. Kidney Int. 2023. PMID: 36270561 Free article. Clinical Trial.
Therapy options for adrenal insufficiency and recommendations for the management of adrenal crisis.
Nowotny H, Ahmed SF, Bensing S, Beun JG, Brösamle M, Chifu I, Claahsen van der Grinten H, Clemente M, Falhammar H, Hahner S, Husebye E, Kristensen J, Loli P, Lajic S, Reisch N; Endo ERN (MTG1). Nowotny H, et al. Among authors: kristensen j. Endocrine. 2021 Mar;71(3):586-594. doi: 10.1007/s12020-021-02649-6. Epub 2021 Mar 4. Endocrine. 2021. PMID: 33661460 Free PMC article. Review.
Non-cardiac causes of troponin elevation.
Petersen M, Strandkjær N, Kristensen JH, Afzal S, Kamstrup P, Pedersen CK, Stengaard C, Nybo M, Overgaard M, Ladefoged SA, Iversen K, Hasselbalch RB. Petersen M, et al. Among authors: kristensen jh. Ugeskr Laeger. 2023 May 15;185(20):V12220753. Ugeskr Laeger. 2023. PMID: 37264867 Free article. Review. Danish.
Definition and delimitation of multimorbidity.
Willadsen TG, Holm A, Kristensen J, Waldorff FB, Reventlow S, Prior A. Willadsen TG, et al. Among authors: kristensen j. Ugeskr Laeger. 2023 Oct 16;185(42):V05230340. Ugeskr Laeger. 2023. PMID: 37897386 Free article. Review. Danish.
Attainment of Target Antibiotic Levels by Oral Treatment of Left-Sided Infective Endocarditis: A POET Substudy.
Bock M, Theut AM, van Hasselt JGC, Wang H, Fuursted K, Høiby N, Lerche CJ, Ihlemann N, Gill S, Christiansen U, Nielsen HL, Lemming L, Elming H, Povlsen JA, Bruun NE, Høfsten D, Fosbøl EL, Køber L, Schultz M, Pries-Heje MM, Kristensen JH, Christensen JJ, Rosenvinge FS, Pedersen CT, Helweg-Larsen J, Tønder N, Iversen K, Bundgaard H, Moser C. Bock M, et al. Among authors: kristensen jh. Clin Infect Dis. 2023 Jul 26;77(2):242-251. doi: 10.1093/cid/ciad168. Clin Infect Dis. 2023. PMID: 36947131
Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers : A Randomized Controlled Trial.
Bundgaard H, Bundgaard JS, Raaschou-Pedersen DET, von Buchwald C, Todsen T, Norsk JB, Pries-Heje MM, Vissing CR, Nielsen PB, Winsløw UC, Fogh K, Hasselbalch R, Kristensen JH, Ringgaard A, Porsborg Andersen M, Goecke NB, Trebbien R, Skovgaard K, Benfield T, Ullum H, Torp-Pedersen C, Iversen K. Bundgaard H, et al. Among authors: kristensen jh. Ann Intern Med. 2021 Mar;174(3):335-343. doi: 10.7326/M20-6817. Epub 2020 Nov 18. Ann Intern Med. 2021. PMID: 33205991 Free PMC article. Clinical Trial.
Personalized phosphoproteomics identifies functional signaling.
Needham EJ, Hingst JR, Parker BL, Morrison KR, Yang G, Onslev J, Kristensen JM, Højlund K, Ling NXY, Oakhill JS, Richter EA, Kiens B, Petersen J, Pehmøller C, James DE, Wojtaszewski JFP, Humphrey SJ. Needham EJ, et al. Among authors: kristensen jm. Nat Biotechnol. 2022 Apr;40(4):576-584. doi: 10.1038/s41587-021-01099-9. Epub 2021 Dec 2. Nat Biotechnol. 2022. PMID: 34857927
DARK Classics in Chemical Neuroscience: NBOMes.
Poulie CBM, Jensen AA, Halberstadt AL, Kristensen JL. Poulie CBM, et al. Among authors: kristensen jl. ACS Chem Neurosci. 2020 Dec 2;11(23):3860-3869. doi: 10.1021/acschemneuro.9b00528. Epub 2019 Nov 12. ACS Chem Neurosci. 2020. PMID: 31657895 Free PMC article. Review.
825 results